Evaluation of the potential for QTc prolongation in patients with solid tumors receiving nivolumab

被引：0
|
作者：
Shruti Agrawal
Ian Waxman
Alexandre Lambert
Amit Roy
Raymond Darbenzio
机构：
[1] Bristol-Myers Squibb,
[2] Bristol-Myers Squibb,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2016年 / 77卷
关键词：
Cancer; ECG; Nivolumab; QT interval; QTc; Solid tumor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：635 / 641
页数：6
相关论文
共 50 条
  • [1] Evaluation of the potential for QTc prolongation in patients with solid tumors receiving nivolumab
    Agrawal, Shruti
    Waxman, Ian
    Lambert, Alexandre
    Roy, Amit
    Darbenzio, Raymond
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (03) : 635 - 641
  • [2] Evaluation of the Potential for QTc Prolongation With Repeated Oral Doses of Fedratinib in Patients With Advanced Solid Tumors
    Ogasawara, Ken
    Xu, Christine
    Yin, Jian
    Darpo, Borje
    Carayannopoulos, Leon
    Xue, Hongqi
    Palmisano, Maria
    Krishna, Gopal
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2021, 10 (04): : 366 - 375
  • [3] Evaluation of the potential for QTc prolongation with avelumab
    Yulia Vugmeyster
    Gülseren Güzel
    Meliessa Hennessy
    Anja H. Loos
    Haiqing Dai
    [J]. Cancer Chemotherapy and Pharmacology, 2019, 84 : 1017 - 1026
  • [4] Evaluation of the potential for QTc prolongation with avelumab
    Vugmeyster, Yulia
    Guezel, Guelseren
    Hennessy, Meliessa
    Loos, Anja H.
    Dai, Haiqing
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 84 (05) : 1017 - 1026
  • [5] QTc prolongation among hospitalized patients receiving methadone
    Schmittner, John
    Krantz, Mori J.
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (20) : 2289 - 2289
  • [6] EVALUATION OF QTC PROLONGATION IN CYSTIC FIBROSIS PATIENTS RECEIVING AZITHROMCIN FOR TREATMENT OF PULMONARY INFLAMMATION
    MacAleese, R. A.
    Kirkby, S. E.
    Novak, K. J.
    [J]. PEDIATRIC PULMONOLOGY, 2015, 50 : 352 - 352
  • [7] An evaluation of factors associated with QTc-Interval prolongation in patients receiving propofol.
    Scalese, Michael
    Herring, Holly
    Rathbun, R. Chris
    Skrepnek, Grant
    Ripley, Toni
    [J]. PHARMACOTHERAPY, 2014, 34 (10): : E186 - E186
  • [8] Evaluation of Medication-Related QTc Prolongation Risks in Patients Receiving Hospice Care
    Protus, Bridget McCrate
    Lovell, Amanda
    [J]. JOURNAL OF PAIN AND SYMPTOM MANAGEMENT, 2019, 57 (02) : 470 - 470
  • [9] Assessment of the potential for QTc prolongation by the investigational ATR inhibitor tuvusertib in patients with advanced solid tumors using integrated nonclinical and clinical assessments
    Mukker, Jatinder Kaur
    Yap, Timothy A.
    Tolcher, Anthony W.
    de Bono, Johann S.
    Plummer, Ruth
    Kulkarni, Rohan
    Witjes, Han
    Diderichsen, Paul Matthias
    Krebs-Brown, Axel
    Strotmann, Rainer
    Szucs, Zoltan
    Gounaris, Loannis
    Venkatakrishnan, Karthik
    [J]. MOLECULAR CANCER THERAPEUTICS, 2023, 22 (12)
  • [10] Risk Factors and Prevalence of QTc Prolongation in Adult Burn Patients Receiving Methadone
    Walroth, Todd A.
    Boyd, Allison N.
    Hester, Allison M.
    Schoenle, Marilyn K.
    Hartman, Brett C.
    Sood, Rajiv
    [J]. JOURNAL OF BURN CARE & RESEARCH, 2020, 41 (02): : 416 - 420
12345